loader from loading.io

Medical App for Medication Management Supports Clinicians and Patients with Anne Meneghetti epocrates TRANSCRIPT

Empowered Patient Podcast

Release Date: 11/12/2025

How AI is Transforming Medical Coding  and Impacting Hospital Revenue Cycle Management with Linda Schatz AKASA TRANSCRIPT show art How AI is Transforming Medical Coding and Impacting Hospital Revenue Cycle Management with Linda Schatz AKASA TRANSCRIPT

Empowered Patient Podcast

Linda Schatz, Director of AKASA, explains the role of Clinical Documentation Integrity (CDI) specialists in ensuring accurate coding and bridging the gap between clinical documentation and specific, accurate codes to ensure proper reimbursement. The complexity of medical coding often leads to errors, which can be nearly eliminated by using AI to review 100% of patient encounters to identify inconsistencies and help CDI and coding professionals process more accurate claims quickly. Accurate documentation is important for hospital revenue, patient care quality, and perception of the hospital's...

info_outline
How AI is Transforming Medical Coding and Impacting Hospital Revenue Cycle Management with Linda Schatz AKASA show art How AI is Transforming Medical Coding and Impacting Hospital Revenue Cycle Management with Linda Schatz AKASA

Empowered Patient Podcast

Linda Schatz, Director of AKASA, explains the role of Clinical Documentation Integrity (CDI) specialists in ensuring accurate coding and bridging the gap between clinical documentation and specific, accurate codes to ensure proper reimbursement. The complexity of medical coding often leads to errors, which can be nearly eliminated by using AI to review 100% of patient encounters to identify inconsistencies and help CDI and coding professionals process more accurate claims quickly. Accurate documentation is important for hospital revenue, patient care quality, and perception of the hospital's...

info_outline
Extending Transplant Access with Diagnostics and Living Donors with Tina Liedtky Thermo Fisher Scientific TRANSCRIPT show art Extending Transplant Access with Diagnostics and Living Donors with Tina Liedtky Thermo Fisher Scientific TRANSCRIPT

Empowered Patient Podcast

Tina Liedtky, President of Transplant Diagnostics at Thermo Fisher Scientific, identifies the significant challenges in the US organ transplant system that must be addressed to meet the demand for organs.  Patient access to transplant care is hindered by geography, the need to match donors and recipients, and the threat of organ rejection. Living donations, particularly of kidneys and livers, are a solution to address the organ shortage, as organs from living donors often lead to better outcomes and can be scheduled to avoid damage caused by organ transportation. Tina explains, "So first...

info_outline
Extending Transplant Access with Diagnostics and Living Donors with Tina Liedtky Thermo Fisher Scientific show art Extending Transplant Access with Diagnostics and Living Donors with Tina Liedtky Thermo Fisher Scientific

Empowered Patient Podcast

Tina Liedtky, President of Transplant Diagnostics at Thermo Fisher Scientific, identifies the significant challenges in the US organ transplant system that must be addressed to meet the demand for organs.  Patient access to transplant care is hindered by geography, the need to match donors and recipients, and the threat of organ rejection. Living donations, particularly of kidneys and livers, are a solution to address the organ shortage, as organs from living donors often lead to better outcomes and can be scheduled to avoid damage caused by organ transportation. Tina explains, "So first...

info_outline
Using Big Data and AI to Uncover Disease Patterns  and Improve Predictive Analytics with Dr. Sev MacLaughlin DeLorean AI TRANSCRIPT show art Using Big Data and AI to Uncover Disease Patterns and Improve Predictive Analytics with Dr. Sev MacLaughlin DeLorean AI TRANSCRIPT

Empowered Patient Podcast

Dr. Sev MacLaughlin, the CEO of DeLorean AI, has developed an AI platform to identify at-risk patients, including those with renal disease, cardiovascular disease, and mental health conditions. Serving smaller and mid-sized provider clinics, this approach supports the shift to value-based care by predicting adverse events, recommending preventive measures, and reducing hospitalizations and healthcare costs. By analyzing entire populations instead of samples, the platform avoids biases and overlooked subgroups inherent in traditional analytical methods. Sev explains, "So I think there's an...

info_outline
Using Big Data and AI to Uncover Disease Patterns and Improve Predictive Analytics with Dr. Sev MacLaughlin DeLorean AI show art Using Big Data and AI to Uncover Disease Patterns and Improve Predictive Analytics with Dr. Sev MacLaughlin DeLorean AI

Empowered Patient Podcast

Dr. Sev MacLaughlin, the CEO of DeLorean AI, has developed an AI platform to identify at-risk patients, including those with renal disease, cardiovascular disease, and mental health conditions. Serving smaller and mid-sized provider clinics, this approach supports the shift to value-based care by predicting adverse events, recommending preventive measures, and reducing hospitalizations and healthcare costs. By analyzing entire populations instead of samples, the platform avoids biases and overlooked subgroups inherent in traditional analytical methods. Sev explains, "So I think there's an...

info_outline
How Connected Medical Devices are Changing Impact of Remote Patient Monitoring with Antoine Pivron Withings TRANSCRIPT show art How Connected Medical Devices are Changing Impact of Remote Patient Monitoring with Antoine Pivron Withings TRANSCRIPT

Empowered Patient Podcast

Antoine Pivron, Vice President of Health Solutions in the B2B division at Withings, highlights the clinical-grade connected devices that are changing the remote patient monitoring market. The equipment and AI-enhanced tools are designed to focus on personalized patient engagement and retention, ultimately leading to improved health outcomes. The data made available identifies trends over time, allowing for intervention when necessary, and is presented in a form that emphasizes prevention rather than reaction. Antoine explains, "We are very well known for our connected devices, especially the...

info_outline
How Connected Medical Devices are Changing Impact of Remote Patient Monitoring with Antoine Pivron Withings show art How Connected Medical Devices are Changing Impact of Remote Patient Monitoring with Antoine Pivron Withings

Empowered Patient Podcast

Antoine Pivron, Vice President of Health Solutions in the B2B division at Withings, highlights the clinical-grade connected devices that are changing the remote patient monitoring market. The equipment and AI-enhanced tools are designed to focus on personalized patient engagement and retention, ultimately leading to improved health outcomes. The data made available identifies trends over time, allowing for intervention when necessary, and is presented in a form that emphasizes prevention rather than reaction. Antoine explains, "We are very well known for our connected devices, especially the...

info_outline
Turning Cold Tumors Hot to  Effectively Treat Triple-Negative Breast Cancer with Dr. Jay Lalezari CytoDyn TRANSCRIPT show art Turning Cold Tumors Hot to Effectively Treat Triple-Negative Breast Cancer with Dr. Jay Lalezari CytoDyn TRANSCRIPT

Empowered Patient Podcast

Dr. Jay Lalezari, CEO of CytoDyn, is focused on solid tumor immunology, particularly in triple-negative breast cancer, where their lead drug, leronlimab, is showing significant long-term survival benefits.  This monoclonal antibody targets the CCR5 receptor, converting cold tumors into hot tumors and making them more susceptible to immunotherapy checkpoint inhibitors. Work with leronlimab for 20 years has demonstrated the potential for use in colorectal cancer as well as TNBC, and to vastly expand the patient population that could benefit from immunotherapy. Jay explains, "When I became...

info_outline
Turning Cold Tumors Hot to  Effectively Treat Triple-Negative Breast Cancer with Dr. Jay Lalezari CytoDyn show art Turning Cold Tumors Hot to Effectively Treat Triple-Negative Breast Cancer with Dr. Jay Lalezari CytoDyn

Empowered Patient Podcast

Dr. Jay Lalezari, CEO of CytoDyn, is focused on solid tumor immunology, particularly in triple-negative breast cancer, where their lead drug, leronlimab, is showing significant long-term survival benefits.  This monoclonal antibody targets the CCR5 receptor, converting cold tumors into hot tumors and making them more susceptible to immunotherapy checkpoint inhibitors. Work with leronlimab for 20 years has demonstrated the potential for use in colorectal cancer as well as TNBC, and to vastly expand the patient population that could benefit from immunotherapy. Jay explains, "When I became...

info_outline
 
More Episodes

Anne Meneghetti, Executive  Director of epocrates, is focused on medication management and providing tools for clinicians to better handle challenges from the increasing population of patients who take multiple drugs and are treating a wide variety of conditions. The epocrates app provides access to drug information, pill identification, checks for interactions, and calculates dosing, reducing medication errors and patient confusion. Polypharmacy patients are further at risk when they are taking over-the-counter drugs and supplements, requiring regular medication reconcilation to avoid serious drug interactions.

Anne explains, "So epocrates has been around since the late 1990s, and it's the number one mobile medical app in the country in terms of physician usership. And it's both a free model and a subscription model. The main reason why clinicians use epocrates is because of the drug information. So, quickly looking up a drug dose, for example, if a drug needs to be prescribed by weight, what is the calculation for that? And there's no way that clinicians can memorize 8,000 drugs. So having it in a quick, easy-to-use app is really crucial in modern times. And sometimes it's not that the clinician doesn't know the dose of the drug, it's just that validation. When you pick up an app and look and see, yep, that's what I thought it was. And that validation, that sense of confidence, is something really precious for a busy clinician. We also use it for drug interactions."

"We find that clinicians really value drug interactions because you can't memorize 8,000 drugs interacting with 8,000 other drugs. And your EHR might tell you if you're trying to prescribe two drugs at the same time, your EHR might tell you, oh, red light, green light, yellow light. But a really good drug reference, like epocrates can tell you, if you're going to prescribe these two drugs together, you need to cut the dose of this one in half and you need to monitor the potassium levels. We find that clinicians really value drug interactions because you can't memorize 8,000 drugs interacting with 8,000 other drugs. And your EHR might tell you if you're trying to prescribe two drugs at the same time, your EHR might tell you, oh, red light, green light, yellow light. But a really good drug reference, like epocrates can tell you, if you're going to prescribe these two drugs together, you need to cut the dose of this one in half and you need to monitor the potassium levels."   

#epocrates #MedicationManagement #Polypharmacy #DrugInteractions #DigitalHealth

epocrates.com

Listen to the podcast here

epocrates